SS 31 30mg

SS‑31 – 30mg

Mitochondria‑Targeted Peptide (Elamipretide) • Lyophilized Powder • Research Use Only

Description: SS‑31 (also known as elamipretide) is a targeted mitochondrial peptide designed to bind cardiolipin within the inner mitochondrial membrane. This unique interaction helps stabilize mitochondrial structure, enhance electron‑transport efficiency, and reduce reactive oxygen species (ROS). SS‑31 is widely studied for its ability to boost ATP production, protect cells from oxidative damage, and prevent mitochondrial‑driven apoptosis.

Research models highlight SS‑31’s potential across energy metabolism, muscle performance, organ protection, and neuroprotection, making it a leading compound in mitochondrial‑medicine and cellular‑aging studies.

Specifications

• Peptide: SS‑31 (Elamipretide)

• Purity: ≥99.8%

• Form: Lyophilized powder

• Quantity: 30mg per vial

• Storage:

  • Store at –20°C (–4°F)

  • Protect from moisture and prolonged light exposure

  • After reconstitution, refrigerate at 2–8°C (36–46°F); use within 30 days

• Grade: Research Use Only — Not for human consumption, therapeutic, or diagnostic use

Key Research Insights

• Cellular Energy & Vitality SS‑31 enhances ATP production by optimizing electron‑transport‑chain efficiency, often resulting in improved cellular energy and reduced fatigue in preclinical models.

• Muscle & Endurance Recovery Studies suggest SS‑31 improves exercise tolerance, supports skeletal‑muscle mitochondrial quality, and may help reverse age‑related muscle decline.

• Organ Protection & Repair Research indicates SS‑31 protects heart, kidney, and other vital organs by reducing oxidative stress, inflammation, ischemic injury, and tissue scarring.

• Neuroprotection Preclinical data shows SS‑31 may restore mitochondrial function in neural tissue, supporting cognitive resilience and reducing secondary injury after trauma.

Mechanistic Interest

SS‑31 is studied for its ability to:

• Bind and stabilize cardiolipin in mitochondrial membranes

• Reduce ROS and oxidative damage

• Enhance ATP synthesis and metabolic efficiency

• Prevent mitochondrial‑mediated apoptosis

• Improve organ resilience under metabolic or ischemic stress

• Support neuroprotective and cognitive‑function pathways

Its targeted mitochondrial action makes SS‑31 a central peptide in bioenergetics, organ‑protection, and longevity‑research models.

Regulatory & Research Context

• Investigational Status: Studied clinically for rare mitochondrial disorders such as Barth syndrome

• Off‑Label Research: Use in general anti‑aging, performance, or energy‑enhancement models falls outside FDA‑approved guidelines

NOTICE

FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION.